Page last updated: 2024-08-25

artemisinin and Cancer of Cervix

artemisinin has been researched along with Cancer of Cervix in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, H; Cao, J; Ji, R; Lu, Z; Luo, J; Tang, Y; Yang, H; Zhang, S; Zhou, X; Zhou, Y; Zhu, W1
Belinson, JL; Goodrich, SK; Schlegel, CR; Wang, G1
Cao, JP; Fu, S; Gong, XM; Torossian, A; Zhang, Q1

Reviews

1 review(s) available for artemisinin and Cancer of Cervix

ArticleYear
Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review.
    Future oncology (London, England), 2014, Volume: 10, Issue:4

    Topics: Alphapapillomavirus; Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Cell Line, Transformed; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Humans; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Neoplasms

2014

Other Studies

2 other study(ies) available for artemisinin and Cancer of Cervix

ArticleYear
Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo.
    Radiation oncology (London, England), 2014, Mar-25, Volume: 9

    Topics: Animals; Artemisinins; Artesunate; Carcinoma; Female; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2014
Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:5

    Topics: Anti-Infective Agents; Apoptosis; Artemisinins; Blotting, Western; Cell Cycle Proteins; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Female; Fibroblasts; G2 Phase; Humans; Radiation Tolerance; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms; X-Rays

2012